CoChat

The Role of Dopamine in Symptoms and Treatment of Apathy in Alzheimer's Disease

Open access
Mitchell, Robert A., Herrmann, Nathan, Lanctôt, Krista L. · 2011 · CNS Neuroscience & Therapeutics
Cited by 139

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Abstract

SUMMARY: Background:Alzheimer's disease (AD) is characterized by a number of serious and debilitating behavioral and psychological symptoms of dementia (BPSD). The most common of these BPSD is apathy, which represents a major source of morbidity and premature institutionalization in the AD population. Many studies have identified discrete changes to the dopaminergic (DAergic) system in patients with AD. The DAergic system is closely related to the brain reward system (BRS) and some studies have suggested that dysfunction in the DAergic system may account for symptoms of apathy in the AD population.Method:Changes to the dopamine (DA) system in AD will be reviewed, and evidence supporting the involvement of the DAergic system in the development of apathy will be examined. Additionally, some pharmacological interventions with DA activity have been identified. The utility of these treatments in the AD population will be reviewed, with a focus on apathy as an outcome.Results:Evidence presented in this review suggests that DA dysfunction in discrete brain areas is an important correlate of apathy in AD and that the DAergic system may be a rational target for pharmacological treatment of apathy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1755-5949.2010.00161.x

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 31 references

Cited by

See all 139

Metadata

Authors
Mitchell, R. A., Herrmann, N., & Lanctôt, K. L.
Venue
CNS Neuroscience & Therapeutics
Publisher
Wiley
Published
2011-09-23
Volume
17
Issue
5
Pages
411-427
ISSN
  • 1755-5930 (ISSN-L)
  • 1755-5949
OpenAlex
W1623483427
Cited by
139
References
31
FWCI
2.99
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Role of Dopamine in Symptoms and Treatment of Apathy in Alzheimer's Disease. https://app.cochat.ai/papers/10.1111/j.1755-5949.2010.00161.x
The paper
Mitchell, R. A., Herrmann, N., & Lanctôt, K. L. (2011). The Role of Dopamine in Symptoms and Treatment of Apathy in Alzheimer's Disease. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/j.1755-5949.2010.00161.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.